$0.266800
-0.02-8.00%
At close: -
$0.273900
0.00712.66%
After Hours: 7:56 PM EDT
Comments
Loading...
Aptevo Therapeutics (APVO) Forecast
NewsEarningsAptevo Therapeutics (APVO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAptevo Therapeutics (NASDAQ:APVO) Stock Quotes, Forecast and News Summary
Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aptevo Therapeutics (APVO) stock?
You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.
Who are Aptevo Therapeutics (APVO) competitors?
Other companies in Aptevo Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), ABVC BioPharma (NASDAQ:ABVC), Portage Biotech (NASDAQ:PRTG), Viracta Therapeutics (NASDAQ:VIRX) and AquaBounty Techs (NASDAQ:AQB).
What is the forecast, or price target, for Aptevo Therapeutics (APVO) stock?
Aptevo Therapeutics has a consensus price target of $14.00.
What is the current price for Aptevo Therapeutics (APVO)?
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $0.2739 last updated November 21, 2024 at 7:56 PM EST.
Does Aptevo Therapeutics (APVO) pay a dividend?
There are no upcoming dividends for Aptevo Therapeutics.
When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?
Aptevo Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Aptevo Therapeutics (APVO) going to split?
There is no upcoming split for Aptevo Therapeutics.
What sector and industry does Aptevo Therapeutics (APVO) operate in?
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.